Can Vitreous Reflux Affect The Short-Term Treatment Response After Intravitreal Ranibizumab Injection?
Enes UyarFatih UlasYunus AlkanPublished in: Current eye research (2020)
We found that the increase in VR amount did not adversely affect the decrease in MT after intravitreal ranibizumab treatment in AMD and DME patients.